Variable | Medication adherence | COR (95% CI) | AOR (95% CI) | |
Poor (%) | Good (%) | |||
Sex | ||||
Male | 154 (73.3) | 56 (26.7) | 2.58 (1.27 to 5.12) | 1.46 (0.97 to 3.57) |
Female | 99 (51.6) | 93 (48.4) | 1 | 1 |
Age | ||||
<60 | 196 (69) | 88 (31) | 2.38 (1.23 to 4.02) | 1.24 (0.86 to 2.68) |
≥60 | 57 (48.3) | 61 (51.7) | 1 | 1 |
Educational level | ||||
No formal education | 66 (73.3) | 24 (26.7) | 1.84 (1.54 to 4.62)* | 1.56 (1.03 to 4.30)* |
Formal education | 187 (60) | 125 (40) | 1 | 1 |
Residence | ||||
Rural | 120 (72.7) | 45 (27.3) | 2.09 (1.55 to 5.50) | 1.86 (0.98 to 3.53) |
Urban | 133 (56.1) | 104 (43.9) | 1 | 1 |
Comorbidity | ||||
Yes | 108 (76.6) | 33 (23.4) | 2.62 (1.64 to 6.67)** | 1.98 (1.35 to 4.35)** |
No | 145(55.6) | 116(44.4) | 1 | 1 |
Medication cost coverage | ||||
Self-funded | 77 (81.9) | 17 (18.1) | 3.4 (2.04 to 6.62) | 2.05 (1.34 to 4.73) |
Health insurance/free of charge | 176 (57.1) | 132 (42.9) | 1 | 1 |
Number of medication | ||||
≥Triple therapy | 70 (76.1) | 22 (23.9) | 3.18 (1.82 to 8.69) | 2.34 (0.95 to 5.56) |
Dual therapy | 106 (67.9) | 50 (32.1) | 2.12 (1.56 to 7.56) | 1.27 (0.79 to 4.03 |
Monotherapy | 77 (50) | 77 (50) | 1 | 1 |
Knowledge of hypertension and its treatment | ||||
Poor | 137 (77.4) | 40 (22.6) | 3.22 (1.67 to 4.95)** | 2.67 (1.45 to 3.99)* |
Good | 116 (51.6) | 109 (48.4) | 1 | |
Patient–physician relationship | ||||
Poor | 38 (73.1) | 14 (26.9) | 1.56 (1.24 to 6.56) | 1.22 (1.02 to 4.34) |
Good | 222 (63.4) | 128 (36.6) | 1 | 1 |
Unavailability of medication during the COVID-19 pandemic | ||||
Yes | 196 (80) | 49 (20) | 7.02 (3.04 to 14.78)** | 5.05 (2.78 to 12.04)** |
No | 57 (36.3) | 100 (63.7) | 1 | 1 |
Disturbed follow-up visits during the COVID-19 pandemic | ||||
Yes | 187 (69.5) | 82 (30.5) | 1.93 (1.13 to 4.71) | 1.32 (0.6 to 3.45) |
No | 72 (54.1) | 61 (45.9) | 1 | 1 |
*P<0.05, **P<0.001; 1=Reference.
AOR, adjusted OR; COR, crude OR.